Rapidly , tianeptine, an atypical antidepressant initially developed for treating depressive disorders , is emerging as a troubling problem within the opioid landscape. Reports suggest that people are abusing tianeptine for its euphoric effects, resulting in dependence and potentially fatal reactions . While its intended use, the accessibility of

Metaberine, a innovative compound, is gaining notice for its potential therapeutic properties. This specific derivative of berberine appears to offer a separate approach to enhancing metabolic activity and general well-being. Researchers are currently investigating its role in managing conditions like glucose resistance, cognitive decline, and part